Renal excretion of purine bases. Effects of probenecid, benzbromarone and pyrazinamide. 1988

T Yamamoto, and Y Moriwaki, and S Takahashi, and T Hada, and K Higashino
Third Department of Internal Medicine, Hyogo College of Medicine, Japan.

Experiments were conducted which revealed the renal transport mechanism(s) of oxypurines by employing uricosuric agents and pyrazinamide. All specimens being drawn from healthy, normal subjects, the data showed that probenecid increased fractional uric acid, fractional hypoxanthine and fractional xanthine clearance, 3.97-, 1.52- and 2.31-fold, respectively, while benzbromarone increased fractional uric acid clearance 2.11-fold, decreased fractional xanthine clearance 0.48-fold and had no effect on fractional hypoxanthine clearance. In addition, pyrazinamide decreased both fractional uric acid clearance 0.35-fold and fractional xanthine clearance 0.44-fold but increased fractional hypoxanthine clearance 1.49-fold. These results suggest the possibility of differing renal transport mechanisms among the purine bases, uric acid, hypoxanthine and xanthine.

UI MeSH Term Description Entries
D007042 Hypoxanthines Purine bases related to hypoxanthine, an intermediate product of uric acid synthesis and a breakdown product of adenine catabolism.
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D011339 Probenecid The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy. Benecid,Benemid,Benuryl,Pro-Cid,Probecid,Probenecid Weimer
D011687 Purines A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.
D011718 Pyrazinamide A pyrazine that is used therapeutically as an antitubercular agent. Tisamid
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001553 Benzbromarone Uricosuric that acts by increasing uric acid clearance. It is used in the treatment of gout. Acifugan,Benzbromaron,Benzbromaron AL,Benzbromaron-Ratiopharm,Besuric,Desuric,Narcaricin,Urinorm,AL, Benzbromaron,Benzbromaron Ratiopharm

Related Publications

T Yamamoto, and Y Moriwaki, and S Takahashi, and T Hada, and K Higashino
October 1988, Biochemical pharmacology,
T Yamamoto, and Y Moriwaki, and S Takahashi, and T Hada, and K Higashino
January 1987, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
T Yamamoto, and Y Moriwaki, and S Takahashi, and T Hada, and K Higashino
January 1973, Acta pathologica et microbiologica Scandinavica. Section B: Microbiology and immunology,
T Yamamoto, and Y Moriwaki, and S Takahashi, and T Hada, and K Higashino
August 1959, The Journal of pharmacology and experimental therapeutics,
T Yamamoto, and Y Moriwaki, and S Takahashi, and T Hada, and K Higashino
December 1970, Life sciences. Pt. 1: Physiology and pharmacology,
T Yamamoto, and Y Moriwaki, and S Takahashi, and T Hada, and K Higashino
January 1981, The Journal of international medical research,
T Yamamoto, and Y Moriwaki, and S Takahashi, and T Hada, and K Higashino
October 1957, Antibiotic medicine & clinical therapy (New York, NY),
T Yamamoto, and Y Moriwaki, and S Takahashi, and T Hada, and K Higashino
December 1984, Klinische Wochenschrift,
T Yamamoto, and Y Moriwaki, and S Takahashi, and T Hada, and K Higashino
November 1977, The American journal of medicine,
T Yamamoto, and Y Moriwaki, and S Takahashi, and T Hada, and K Higashino
December 1993, Journal of pharmaceutical sciences,
Copied contents to your clipboard!